1Maley A, Warren M, Haberman I, Swerlick R, Kharod-Dholakia B, Feldman RJ. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP). J Am Acad Dermatol2016; 74: 835–840.
3Foster CS, Chang PY, Ahmed AR. Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid. Ophthalmology2010; 117: 861–869.
4Steger B, Madhusudan S, Kaye SBet al. Combined use of rituximab and intravenous immunoglobulin for severe autoimmune cicatricial conjunctivitis - an interventional case series. Cornea2016; 35: 1611–1614.
6He Y, Shimoda M, Ono Yet al. Persistence of autoreactive IgA-secreting B cells despite multiple immunosuppressive medications including rituximab. JAMA Dermatology2015; 151: 646–650.
9Nagelkerke SQ, Kuijpers TW. Immunomodulation by IVIg and the role of Fc-gamma receptors: classic mechanisms of action after all?Front Immunol2015; 5: 674.
Please check your email for instructions on resetting your password.
If you do not receive an email within 10 minutes, your email address may not be registered,
and you may need to create a new Wiley Online Library account.
Request Username
Can't sign in? Forgot your username?
Enter your email address below and we will send you your username
If the address matches an existing account you will receive an email with instructions to retrieve your username
The full text of this article hosted at iucr.org is unavailable due to technical difficulties.
